Abstract
N-methylpurine-DNA glycosylase (MPG), a ubiquitous DNA repair enzyme, initiates excision repair of several N-alkylpurine adducts, deaminated and lipid peroxidation-induced purine adducts. MPG from human and mouse has previously been cloned and expressed. However, due to the poor expression level in Escherichia coli (E. coli) and multi-step purification process of full-length MPG, most successful attempts have been limited by extremely poor yield and stability. Here, we have optimized the codons within the first 5 residues of human MPG (hMPG) to the best used codons for E. coli and expressed full-length hMPG in large amounts. This high expression level in conjunction with a strikingly high isoelectric point (9.65) of hMPG, in fact, helped purify the enzyme in a single step. A previously well-characterized monoclonal antibody having an epitope in the N-terminal tail could detect this codon-optimized hMPG protein. Surface plasmon resonance studies showed an equilibrium binding constant (KD) of 0.25 nM. Steady-state enzyme kinetics showed an apparent Km of 5.3 nM and kcat of 0.2 min-1 of MPG for the hypoxanthine (Hx) cleavage reaction. Moreover, hMPG had an optimal activity at pH 7.5 and 100 mM KCl. Unlike the previous reports by others, this newly purified full-length hMPG is appreciably stable at high temperature, such as 50°C. Thus, this study indicates that this improved expression and purification system will facilitate large scale production and purification of a stable human MPG protein for further biochemical, biophysical and structure-function analysis.
Introduction
Cellular DNA is continuously exposed to endogenous or exogenous chemical or physical agents that induce DNA lesions. DNA base damage threatens genomic stability and cellular viability. Multiple DNA repair pathways exist in all organisms, from bacteria to humans, to preserve the integrity of the genome [1]. If not repaired, damaged bases could be mutagenic [2] and/or cause cell death by blocking DNA replication [3]. In all organisms, repair of DNA-containing small adducts, as well as altered and abnormal bases, occurs primarily via the base excision repair (BER) pathway, beginning with cleavage of the base by a DNA glycosylase [1-5]. Monofunctional DNA glycosylases, such as N-methylpurine-DNA glycosylase (MPG) and uracil-DNA glycosylase, use an activated water molecule as a nucleophile to generate an apurinic or apyrimidinic (AP) site in DNA. Mammalian MPG is known to excise at least 17 structurally diverse modified bases from DNA [6]. These lesions include 3-alkylpurine, 7-alkylguanine, 1,N6-ethenoadenine (εA), N2,3-ethenoguanine, and hypoxanthine (Hx), all of which are purine derivatives [7–12]. Recently, we showed that Mg2+ could inhibit MPG's activity by abrogating its substrate binding and decreasing the active enzyme concentration, and the Mg2+-mediated inhibition might be considered as a regulator for balanced BER as all the downstream BER enzymes, other than MPG, require Mg2+ for their optimum repair activity [13].
Besides the importance of MPG, most of the enzymatic and structural properties, which are currently available in literature, are primarily for the truncated protein. The major reasons include extremely poor expression of full-length hMPG, which made its purification extremely difficult, and so the latter required a multi-step process [10]. Also, we have shown before, by systematic deletion analysis of MPG from N- and C-termini, that a minimally sized polypeptide (NΔ100CΔ18) lacking 100 and 18 amino acid residues from the amino and carboxyl termini, respectively, and wild-type enzyme had similar kinetic and binding properties for εA [7]. Since then, there were several reports on the crystallographic structures of similarly truncated protein in complex with εA or control DNA [14 – 16]. But our recent studies indicate that the structural information on εA-truncated MPG complex is not sufficient and does not reveal the full scenario for other DNA adducts including Hx [17, 18].
Moreover, we have reported that we could easily express and purify ΔExon 1 hMPG in large amounts from E.coli [17]. Therefore, in this study we have optimized the codon within the 1st exon sequence of hMPG to the best used codons for E.coli without changing the amino acid residues. The codon optimized sequence has improved the expression and purification process significantly, so that we could purify full-length hMPG in a single step. The purified active protein showed similar properties as reported earlier [10] but with improved thermal stability. In the future, this expression and purification system could be used for large scale purification of full-length hMPG that may lead to the crystallographic and spectroscopic studies which require active and stable protein in large amounts.
Materials and Methods
Construction of expression plasmids for full-length codon-optimized human MPG
Polymerase chain reaction was carried out to generate full-length hMPG using ΔExon1 hMPG expression vector, reported previously [17] as template and a set of primers which include forward primer (5′-CATATGGTGACCCCGGCGTTGCAGATGAAG-3′) and the reverse primer (5′-GAATTCTCAGGCCTGTGTGTCCTGCT-3′). The forward primer contains an NdeI site at the 5′ end and harbors sequences for Exon Ia with the codons (underlined) best used for translation in E.coli. The 3′ of the PCR product ended with MPG's internal stop codon and also included an EcoR1 site after the stop codon. Thus, a full-length hMPG cDNA with the codons optimized at the N-terminus was amplified. The PCR products were then subcloned in TA cloning vector, digested with NdeI and EcoRI and subcloned into expression vector pRSETB at NdeI/EcoRI sites, allowing us to express a nonfusion hMPG protein. The identity of the construct was confirmed by DNA sequencing.
Purification of full-length human MPG
E. coli BL21(DE3) carrying the construct with the hMPG full-length optimized sequence was grown in magnificient broth (MacConnell Research, CA) at 37°C until the absorbance at 600 nm reached 0.6. The culture was cooled to 25°C and, after the addition of IPTG to 1 mM, was grown at 25°C for 6 h, prior to chilling to 0°C. All subsequent procedures were carried out at 4°C. After the bacteria were harvested by centrifugation, they were resuspended in buffer A (40 mM Tris-HCl, pH 8.5, 120 mM NaCl, and 0.1% Tween-20, 1 mM DTT, 10% glycerol, 1X protease inhibitor [Complete EDTA-free protease inhibitor cocktail tablet, Roche Diagnostics, IN]) and then sonicated (10 × 45 s) on ice at full power using a Braun-Sonic U. After centrifugation of the cell lysate (2×30 min at 15,000 ×g), the supernatant was applied to ion exchange columns, SP Sepharose (1 ml) (Amersham Pharmacia Biotech, Piscataway, NJ). The columns were pre-equilibrated with buffer A. After washing with buffer A, the protein bound with SP Sepharose was eluted with a linear gradient of NaCl (120 to 550 mM) in buffer A. The electrophoretically pure peak fractions were pooled and kept at -80°C in aliquots.
Western blot analysis
Purified MPG (100 ng) was separated by SDS-PAGE (15% polyacrylamide). For Western Blot analysis, proteins were transferred to a nitrocellulose membrane, and the MPG bands were visualized with a previously characterized purified anti-human MPG monoclonal antibody (520-3A; 17) using the enhanced chemi-luminescence protocol (Amersham Life Sciences, Piscataway, NJ).
N-terminal amino acid sequencing
For direct sequencing, SDS–PAGE was performed as above and gels electro-blotted onto PVDF membrane. Membranes were stained for approximately 1min in a freshly made and filtered 0.1% solution of Ponseau S, and destained in water until proteins bands were visible. Protein bands were excised from the membrane and subjected to direct amino acid sequence analysis (Protein Core facility, UTMB, TX; 18).
Preparation of substrates
Hx containing 50-mer oligonucleotides with the sequence 5′-TCGAGGATCCTGAGCTCGAGTCGACGXTCGCGAATTCTGCGGATCCAAGC-3′ (where X represents Hx) was purchased from Gene Link (Hawthorne, NY). The complementary oligonucleotide containing T opposite Hx was synthesized by the Recombinant DNA Laboratory Core Facility at the University of Texas Medical Branch (Galveston, TX). The oligonucleotides were purified on a polyacrylamide sequencing gel. The Hx oligonucleotide was labeled at the 5′ end using T4 polynucleotide kinase and γ32P-ATP and annealed to complementary oligonucleotide to prepare 32P-end-labeled duplex oligonucleotide as described previously [13].
MPG-mediated excision activity assay
The hMPG protein (15-30 nM) was incubated with 1 nM oligonucleotides in the presence of buffer that differed in pH (5.5-9.6) and ionic strength (15-200 mM KCl). The standard reaction mixtures contained 1 mM DTT, 10 μg/ml nuclease-free BSA, and 10% glycerol with different pH or ionic strength in a total volume of 20 μl. Incubation was at 37°C for 10 min, if not otherwise stated. The reaction was stopped by inactivating the enzyme at 75°C for 5 min, and the products were analyzed as described previously [13]. For the thermal stability study, 300 nM proteins was kept at 50°C, and at different time points (0-30 min) aliquots were transferred to separate assay tubes. Mixtures containing 30 nM hMPG and 1 nM Hx-oligonucleotide substrate were subjected for the activity assay described previously (13).
Steady-state kinetic studies
The full-length hMPG (5 nM) was incubated with 5′-32P-labeled Hx-containing duplex oligonucleotide (0–20 nM) substrates for 3 min at 37°C under assay conditions similar to those described above. The reaction products were also analyzed and quantified as described for the activity assay.
DNA binding studies using surface plasmon resonance
To further characterize the newly purified full-length hMPG, we examined its binding with Hx-oligo using a Biacore-T100 (Biacore, Uppsala, Sweden). A 50-mer duplex oligonucleotide containing an Hx at the 26th position from the 5′ end of one strand was used for measuring enzyme-DNA interactions. Oligonucleotides were biotinylated and immobilized on streptavidin-coated Biacore chips (13). Then, we measured the binding parameters of full-length hMPG (0-7.5 nM) using a binding buffer (10 mM HEPES-KOH pH 7.6, 150 mM KCl and 0.5 % surfactant) at 5°C. The MPGs at various concentrations were injected, and the surface plasmon resonance units were measured with 60 sec injection. Following each injection, the chip was regenerated with 1M NaCl. The binding kinetics for oligonucleotides containing Hx was established with a series of MPG concentrations. The Langmuir isotherms (1:1 binding) at various protein concentrations allowed us to calculate the kinetic binding parameters based on on/off rates and protein concentrations.
Results
Purification of full-length human MPG
We replaced the original codons (2nd, 4th and 5th) of hMPG with codons best used in E.coli (Fig. 1) and found an improved expression of hMPG protein. The full-length hMPG protein was then purified to near homogeneity as shown by SDS-PAGE (Fig. 2A). From 4 L of E.coli culture we have purified 6.4 mg protein with an apparent purity of ∼95% revealed by coomassie blue staining. The recovery and purification fold were 80% and ∼125, respectively (Table 1). The high isoelectric point (pI) of MPG (pI=9.65) allowed us to run an SP-sepharose column under a reasonably high pH of 8.5 where most of the E.coli proteins do not bind effectively to the beads.
Table 1.
Purification Step | Total Protein (mg) | Total activity (IU*) | Specific Activity (IU/mg) | Yield (%) | Purification fold |
---|---|---|---|---|---|
Crude Extract | 1000 | 80,000 | 80 | 100 | 1 |
SP-Sepharose | 6.4 | 64,000 | 10,000 | 80 | 125 |
One International Unit (IU) is defined as the activity, which cleaves 50% of 0.5 pmole of double stranded DNA oligo substrate containing a hypoxanthine lesion in 10 min at 37°C.
Western blot analysis and N-terminal amino acid sequencing
We previously characterized a purified moAb 520-3A that recognizes specifically the sequence corresponding to the residues 156 to 246 in the hMPG coding sequence (17). In western blot analysis, this antibody (520-3A) has cross-reacted with purified full-length hMPG (Fig. 2B). Further, the N-terminal sequencing results were similar to what could expect from the coding sequence [10], and thus, confirmed the identity of this protein.
MPG activity assay
The activity of the purified hMPG was measured in the presence of oligonucleotides in buffers adjusted to different pHs (5.5-9.6) (Fig. 3A) and different ionic strength (15-200 mM KCl) (Fig. 3B). Like in earlier reports by others, the hMPG protein showed an optimum activity at pH 7.5 and an ionic strength of 100 mM KCl (10). Most importantly, the protein showed very high thermal stability. At 50°C even 30 minutes of incubation inactivated the protein by only 30%. Thus, contrary to the previous report [10], this newly purified full-length hMPG is stable (Fig. 3C).
Steady-state kinetic study
In a previous study we measured the steady-state kinetic parameters for full-length mouse MPG. Likewise, we measured this for hMPG. The steady-state enzyme kinetics showed an apparent Km of 5.3 nM and kcat of 0.2 min-1 of hMPG for Hx cleavage reaction.
Hx binding studies using surface plasmon resonance
To further characterize full-length hMPG, we examined the MPG-Hx binding using a Biacore-T100 (Biacore, Uppsala, Sweden) (Fig. 4A). Our results showed an equilibrium binding constant (KD) of 0.25 nM (Fig. 4B) for this full-length human protein, similar to that of full-length mouse MPG (18).
Discussion
We have shown before by systematic deletion analysis of MPG from N- and C-termini that a minimally sized polypeptide (NΔ100CΔ18) lacking 100 and 18 amino acid residues from the amino and carboxyl termini, respectively, and wild-type enzyme had similar kinetic and binding properties for εA [7]. Since then, there were several reports on the crystallographic structures of similarly truncated protein in complex with εA or control DNA [14–16]. But we recently showed that the structural information on εA-truncated MPG complex is not sufficient and does not reveal the full scenario for other DNA adducts including Hx [19]. The N-terminally truncated MPG showed less activity compared to the full-length protein towards Hx substrate. Also, with the help of a highly characterized monoclonal antibody with an epitope in the N-terminal tail, we recently showed that the latter appears to have an important role in substrate discrimination, however, with a differential effect on different substrates [17].
In another previous study with a recombinant chimeric protein containing N- and C-terminal halves of human and mouse MPG, we found that the N-terminal half is critical for the recognition of 3-methylguanine and 7-methylguanine [9]. Others also showed that the first 70 amino acid residues of hMPG were indispensable for 1,N2-εG excision reaction [20].
Thus, these results overall also affirm the need for reinvestigation of full-length MPG for its enzymatic and structural properties, which are currently available mostly for the truncated protein. Importantly, the apparent reason of using the truncated protein was largely due to the instability of the human protein, and the latter resulted from extremely poor expression and thus an inefficient purification process. However, while purifying ΔExon1 hMPG, we realized that one could improve the expression by optimizing the Exon 1 codons for E.coli. Indeed, the codon optimization resulted in ample protein expression. Moreover, the advantageous high pI value (9.65) of hMPG allowed us to select a strong cation-exchange (SP-Sepharose) column and optimum buffer systems, so that most of the E.coli protein did not bind to the column, whereas a single linear gradient could purify hMPG in apparent homogeneity in SDS-PAGE. The protein is also highly stable, and thus it can be used in further structural studies, such as X-ray crystallography or biophysical analysis.
Acknowledgments
We thank Ms. Karen Howenstein for expert editorial and adminstrative help. We would like to thank Ms. Linshan Yuan for her excellent technical help. SPR experiments were performed at the Biacore Molecular Interactions Shared Resource (BMISR) of the Lombardi Comprehensive Cancer Center, which is supported by an NCI grant (NIH P30 CAS1008). The work was supported by NIH grants RO1 CA 92306 (RR) and RO1 CA 108641 (AU).
Abbreviations
- BER
base excision repair
- MPG
N-Methylpurine DNA-glycosylase
- Hx
Hypoxanthine
- εA
1,N6ethenoadenine
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Lindahl T. Instability and decay of the primary structure of DNA. Nature. 1993;362:709–715. doi: 10.1038/362709a0. [DOI] [PubMed] [Google Scholar]
- 2.Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger TE. DNA Repair and Mutagenesis. American Society for Microbiology. 2006:169–226. [Google Scholar]
- 3.Larson K, Sahm J, Shenkar R, Strauss B. Methylation-induced blocks to in vitro DNA replication. Mutat Res. 1985;150:77–84. doi: 10.1016/0027-5107(85)90103-4. [DOI] [PubMed] [Google Scholar]
- 4.Breimer L, Lindahl T. DNA glycosylase activities for thymine residues damaged by ring saturation, fragmentation, or ring contraction are functions of endonuclease III in Escherichia coli. J Biol Chem. 1984;259:5543–5548. [PubMed] [Google Scholar]
- 5.Hatahet Z, Kow YW, Purmal AA, Cunningham RP, Wallace SS. New substrates for old enzymes. 5-Hydroxy-2′-deoxycytidine and 5-hydroxy-2′-deoxyuridine are substrates for Escherichia coli endonuclease III and formamidopyrimidine DNA N-glycosylase, while 5-hydroxy-2′-deoxyuridine is a substrate for uracil DNA N-glycosylase. J Biol Chem. 1994;269:18814–18820. [PubMed] [Google Scholar]
- 6.Singer B, Hang B. What structural features determine repair enzyme specificity and mechanism in chemically modified DNA? Chem Res Tox. 1997;10:713–732. doi: 10.1021/tx970011e. [DOI] [PubMed] [Google Scholar]
- 7.Roy R, Biswas T, Hazra TK, Roy G, Grabowski DT, Izumi T, Srinivasan G, Mitra S. Specific interaction of wild-type and truncated mouse N-methylpurine-DNA glycosylase with ethenoadenine-containing DNA. Biochemistry. 1998;37:580–589. doi: 10.1021/bi972313l. [DOI] [PubMed] [Google Scholar]
- 8.Roy R, Brooks C, Mitra S. Purification and biochemical characterization of recombinant N-methylpurine-DNA glycosylase of the mouse. Biochemistry. 1994;33:15131–15140. doi: 10.1021/bi00254a024. [DOI] [PubMed] [Google Scholar]
- 9.Roy R, Kennel SJ, Mitra S. Distinct substrate preference of human and mouse N-methylpurine-DNA glycosylases. Carcinogenesis. 1996;17:2177–2182. doi: 10.1093/carcin/17.10.2177. [DOI] [PubMed] [Google Scholar]
- 10.O'Connor TR. Purification and characterization of human 3-methyladenine-DNA glycosylase. Nucl Acids Res. 1993;21:5561–5569. doi: 10.1093/nar/21.24.5561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Saparbaev M, Laval J. Excision of hypoxanthine from DNA containing dIMP residues by the Escherichia coli, yeast, rat, and human alkylpurine DNA glycosylases. Proc Natl Acad Sci USA. 1994;91:5873–5877. doi: 10.1073/pnas.91.13.5873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dosanjh MK, Roy R, Mitra S, Singer B. 1,N6-ethenoadenine is preferred over 3-methyladenine as substrate by a cloned human N-methylpurine-DNA glycosylase (3-methyladenine-DNA glycosylase) Biochemistry. 1994;33:1624–1628. doi: 10.1021/bi00173a002. [DOI] [PubMed] [Google Scholar]
- 13.Adhikari S, Toretsky JA, Yuan L, Roy R. Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase. J Biol Chem. 2006;281:29525–29532. doi: 10.1074/jbc.M602673200. [DOI] [PubMed] [Google Scholar]
- 14.Lau AY, Wyatt MD, Glassner BJ, Samson LD, Ellenberger TE. Molecular basis for discriminating between normal and damaged bases by the human alkyladenine glycosylase, AAG. Proc Natl Acad Sci U S A. 2000;5:13573–13578. doi: 10.1073/pnas.97.25.13573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Labahn J, Scharer OD, Long A, Ezaz-Nikpay K, Verdine GL, Ellenberger TE. Structural basis for the excision repair of alkylation-damaged DNA. Cell. 1996;86:321–329. doi: 10.1016/s0092-8674(00)80103-8. [DOI] [PubMed] [Google Scholar]
- 16.Lau AY, Scharer OD, Samson L, Verdine GL, Ellenberger T. Crystal structure of a human alkylbase-DNA repair enzyme complexed to DNA: mechanisms for nucleotide flipping and base excision. Cell. 1998;95:249–258. doi: 10.1016/s0092-8674(00)81755-9. [DOI] [PubMed] [Google Scholar]
- 17.Adhikari S, Kennel SJ, Roy G, Mitra PS, Mitra Sankar, Roy Rabindra. Discrimination of lesion removal of N-Methylpurine DNA-glycosylase revealed by a potent neutralizing monoclonal antibody. DNA Repair. doi: 10.1016/j.dnarep.2007.07.012. Article in press. doi: 10.1016 j.dnarep. 007.07.012. epub 2nd Sep. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Liu X, Roy R. Truncation of amino-terminal tail stimulates activity of human endonuclease III (hNTH1) J Mol Biol. 2002;321:265–276. doi: 10.1016/s0022-2836(02)00623-x. [DOI] [PubMed] [Google Scholar]
- 19.Adhikari S, Üren A, Roy R. N-Terminal extension of N-Methylpurine-DNA glycosylase is required for turnover in hypoxanthine excision reaction. J Biol Chem. 2007;282:30078–30084. doi: 10.1074/jbc.M704051200. [DOI] [PubMed] [Google Scholar]
- 20.Saparbaev M, Langouet S, Privezentzev CV, Guengerich FP, Cai H, Elder RH, Laval J. 1,N(2)-ethenoguanine, a mutagenic DNA adduct, is a primary substrate of Escherichia coli mismatch-specific uracil-DNA glycosylase and human alkylpurine-DNA-N-glycosylase. J Biol Chem. 2002;277:26987–26993. doi: 10.1074/jbc.M111100200. [DOI] [PubMed] [Google Scholar]